BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS










 Company News
Stemline Therapeutics, Inc. (STML) Announces Opening Of SL-401 Corporate IND And Start Of Clinical Trials In BPDCN And AML 7/28/2014 7:46:22 AM
Stemline Therapeutics, Inc. (STML) To Present At The 2014 Wells Fargo Securities Healthcare Conference 6/10/2014 9:48:08 AM
Stemline Therapeutics, Inc. (STML) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/28/2014 9:56:21 AM
Stemline Therapeutics, Inc. (STML) Announces Presentation Of SL-401 Preclinical Efficacy Data In Multiple Myeloma At The 2014 American Society of Clinical Oncology Annual Meeting 5/20/2014 9:29:26 AM
Stemline Therapeutics, Inc. (STML) To Present At The Deutsche Bank (DB) 39th Annual Health Care Conference 4/30/2014 9:38:22 AM
Stemline Therapeutics, Inc. (STML) Announces FDA Acceptance Of IND For SL-701, A Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors 4/8/2014 7:39:18 AM
Stemline Therapeutics, Inc. (STML) To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 9:03:48 AM
Stemline Therapeutics, Inc. (STML) Announces Presentation Of SL-501 Preclinical Efficacy Data In TKI-Resistant CML At The Annual Meeting Of The American Association for Cancer Research 4/1/2014 10:20:00 AM
Stemline Therapeutics, Inc. (STML) To Present At The 26th Annual ROTH Conference 3/6/2014 9:34:45 AM
Stemline Therapeutics, Inc. (STML) To Present At Cowen And Company Health Care Conference 2/26/2014 9:02:09 AM
123456